Dordaviprone
Tier C — Watch / tradeDordaviprone
Targets：ClpP, DRD2
Brand：Modeyso
Indications (approved)：Diffuse midline glioma
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| TIC-10-001 | 5464-11-9 | 2-(methylthio)-4,5-dihydro-1H-imidazole hydroiodide |
| TIC-10-002 | 60546-77-2 | methyl 2-(methylthio)-4,5-dihydro-1H-imidazole-1-carboxylate |
| TIC-10-003 | 89-93-0 | o-tolylmethanamine |
| TIC-10-004 | 38941-29-6 | N-(2-methylbenzyl)-4,5-dihydro-1H-imidazol-2-amine |
| TIC-10-005 | 3939-01-3 | methyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride |
Frequently asked questions
What are the approved indications of Dordaviprone?
Approved indications include: Diffuse midline glioma.
When does the Dordaviprone patent expire?
No public expiry year is available for Dordaviprone yet; this page updates once verified.
How many synthesis routes are recorded for Dordaviprone?
1 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Dordaviprone intermediates?
All intermediates in Dordaviprone routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Dordaviprone intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-22